We are live on ! Find out more
ALIM

Alimera Sciences

Delisted

ALIM was delisted on the 13th of September, 2024.

30 hedge funds and large institutions have $146M invested in Alimera Sciences in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1,328% more capital invested

Capital invested by funds: $10.3M → $146M (+$136M)

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

67% more funds holding

Funds holding: 1830 (+12)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

Holders
30
Holders Change
+12
Holders Change %
+66.67%
% of All Funds
0.48%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
12
Increased
5
Reduced
7
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
FWM
26
Focused Wealth Management
New York
$205
Wells Fargo
27
Wells Fargo
California
$121 -$13 -4 -9%
Barclays
28
Barclays
United Kingdom
$112 +$119 +36 New
Comerica Bank
29
Comerica Bank
Texas
$43 +$46 +14 New

ALIM Hedge Fund Activity: Q3 2023 in Review

30 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q3 2023, worth a combined $146M — up 1,328% from $10.3M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new ALIM positions and 0 closed out — a net gain of 12 holders — while 5 added to existing stakes and 7 trimmed.

The largest buyer was Caligan Partners, adding an estimated $54.1M. The largest seller was Bridgeway Capital Management, cutting an estimated $60.5K.

  • 30 institutional investors held Alimera Sciences (ALIM) as of Q3 2023, up from 18 in Q2 2023.
  • Funds reported $146M of Alimera Sciences stock for Q3 2023, up 1,328% quarter-over-quarter.
  • 12 funds opened new Alimera Sciences positions in Q3 2023 and 0 closed out, a net change of +12 holders.
  • The largest Alimera Sciences buyer in Q3 2023 was Caligan Partners, an estimated $54.1M added.
  • The largest Alimera Sciences seller in Q3 2023 was Bridgeway Capital Management, an estimated $60.5K sold.

Based on aggregated 13F filings for Q3 2023.